Fate of the Pfizer Whistleblower Case to Be Decided by Federal Judge in Texas

Fate of the Pfizer Whistleblower Case to Be Decided by Federal Judge in Texas
A health worker prepares a dose of Pfizer-BioNTech's COVID-19 vaccine in Malcha Mall, Jerusalem, December 22, 2021. Ammar Awad/Reuters
Darlene McCormick Sanchez
Zachary Stieber
Updated:
0:00

BEAUMONT, Texas—Attorneys for a whistleblower alleging violations occurred during the Pfizer–BioNTech COVID-19 vaccine clinical trial argued in federal court on March 1 that their case should advance to the discovery phase.

Attorneys for the defendants—Pfizer and two subcontractors, Ventavia Research Group and ICON—tried to convince the judge to dismiss the case. If successful, their clients would avoid depositions under oath.

Darlene McCormick Sanchez is an Epoch Times reporter who covers border security and immigration, election integrity, and Texas politics. Ms. McCormick Sanchez has 20 years of experience in media and has worked for outlets including Waco Tribune Herald, Tampa Tribune, and Waterbury Republican-American. She was a finalist for a Pulitzer prize for investigative reporting.
Related Topics